Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2
- PMID: 21494637
- PMCID: PMC3071839
- DOI: 10.1371/journal.pone.0018568
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2
Abstract
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal dominant familial Parkinson's disease (PD) and also contribute to idiopathic PD. LRRK2 mutations represent the most common cause of PD with clinical and neurochemical features that are largely indistinguishable from idiopathic disease. Currently, transgenic mice expressing wild-type or disease-causing mutants of LRRK2 have failed to produce overt neurodegeneration, although abnormalities in nigrostriatal dopaminergic neurotransmission have been observed. Here, we describe the development and characterization of transgenic mice expressing human LRRK2 bearing the familial PD mutations, R1441C and G2019S. Our study demonstrates that expression of G2019S mutant LRRK2 induces the degeneration of nigrostriatal pathway dopaminergic neurons in an age-dependent manner. In addition, we observe autophagic and mitochondrial abnormalities in the brains of aged G2019S LRRK2 mice and markedly reduced neurite complexity of cultured dopaminergic neurons. These new LRRK2 transgenic mice will provide important tools for understanding the mechanism(s) through which familial mutations precipitate neuronal degeneration and PD.
Conflict of interest statement
Figures







Similar articles
-
Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.Neurobiol Dis. 2014 Nov;71:345-58. doi: 10.1016/j.nbd.2014.08.027. Epub 2014 Aug 29. Neurobiol Dis. 2014. PMID: 25174890 Free PMC article.
-
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.Hum Mol Genet. 2015 Sep 15;24(18):5299-312. doi: 10.1093/hmg/ddv249. Epub 2015 Jun 29. Hum Mol Genet. 2015. PMID: 26123485 Free PMC article.
-
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats.Neurobiol Aging. 2015 Jan;36(1):505-18. doi: 10.1016/j.neurobiolaging.2014.07.011. Epub 2014 Jul 15. Neurobiol Aging. 2015. PMID: 25174649 Free PMC article.
-
Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2.Biochem Soc Trans. 2012 Oct;40(5):1042-6. doi: 10.1042/BST20120112. Biochem Soc Trans. 2012. PMID: 22988862 Free PMC article. Review.
-
Mouse models for LRRK2 Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S186-9. doi: 10.1016/S1353-8020(11)70058-X. Parkinsonism Relat Disord. 2012. PMID: 22166430 Review.
Cited by
-
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6. Proc Natl Acad Sci U S A. 2020. PMID: 32631998 Free PMC article.
-
Short- and long-term effects of LRRK2 on axon and dendrite growth.PLoS One. 2013 Apr 30;8(4):e61986. doi: 10.1371/journal.pone.0061986. Print 2013. PLoS One. 2013. PMID: 23646112 Free PMC article.
-
Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1.Acta Pharmacol Sin. 2015 Aug;36(8):966-75. doi: 10.1038/aps.2015.48. Acta Pharmacol Sin. 2015. PMID: 26238290 Free PMC article.
-
Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain.J Neurosci. 2012 May 30;32(22):7585-93. doi: 10.1523/JNEUROSCI.5809-11.2012. J Neurosci. 2012. PMID: 22649237 Free PMC article.
-
LRRK2 regulation of immune-pathways and inflammatory disease.Biochem Soc Trans. 2019 Dec 20;47(6):1581-1595. doi: 10.1042/BST20180463. Biochem Soc Trans. 2019. PMID: 31769472 Free PMC article. Review.
References
-
- Gasser T. Mendelian forms of Parkinson's disease. Biochim Biophys Acta. 2009;1792:587–596. - PubMed
-
- Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004;44:595–600. - PubMed
-
- Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601–607. - PubMed
-
- Moore DJ. The biology and pathobiology of LRRK2: implications for Parkinson's disease. Parkinsonism Relat Disord. 2008;14:S92–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases